| mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.0001 |
| mRNA |
JW-55 |
CTRPv2 |
pan-cancer |
AAC |
0.28 |
0.0002 |
| mRNA |
PD-0325901 |
GDSC1000 |
pan-cancer |
AAC |
0.12 |
0.0002 |
| mRNA |
dabrafenib |
GDSC1000 |
pan-cancer |
AAC |
0.11 |
0.0003 |
| mRNA |
17-AAG |
GDSC1000 |
pan-cancer |
AAC |
0.11 |
0.0006 |
| mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.0006 |
| mRNA |
nelarabine |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0009 |
| mRNA |
VX-11e |
GDSC1000 |
pan-cancer |
AAC |
0.11 |
0.0009 |
| mRNA |
elocalcitol |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.001 |
| mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.001 |